Search

Filters
Clear All
  • 14
  • 49
  • 624

Phase

  • 12
  • 14
  • 57
  • 8
  • 73
  • 4
  • 510
  • 609
  • 281
  • 674
  • 13

Found 687 in-health trials

A listing of in-health medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

J
Jenny Belsky, DO
5 years - 60 years
All genders
Phase 3
Interventional
This study investigates the use of immunotherapy in treating Hodgkin lymphoma, a type of cancer that affects the lymphatic system. Hodgkin lymphoma is a condition where cells in the lymphatic system grow abnormally and may spread beyond it. The purpose of this study is to compare adding immunotherapy (brentuximab vedotin …
B
Brian Weiss
12 months - 30 years
All genders
Phase 1/2
Interventional
What is the purpose of this study?This phase I/II trial evaluates the highest safe dose, side effects, and possible benefits ofgavivint in treating patients with solid tumors that has come back (recurrent) or does notd to treatment (refractory). Tegavivint interferes with the binding of beta-catenin to TBL1, which may help …
F
Flora Hammond, MD
18 years - 100 years
All genders
What is the purpose of this study?The primary objective of this study is to provide data for research to improve care and outcomes for individuals with traumatic brain injuries. The Traumatic Brain Injury Model System National Database is a multi-center, prospective, longitudinal study used for descriptive analyses of outcome, correlation …
 Food Resources and Kitchen Skills plus Aerobic Training (FoRKS+) for Black Adults with Hypertension
D
Daniel Clark
35 years - 75 years
All genders
Interventional
FoRKS+ is a voluntary research study designed by researchers at the IU School of Medicine in partnership with Eskenazi Health to study the effect of brain-healthy foods and physical activity on cognition for Black adults with high blood pressure in the Eskenazi Health System. 
T
Tareq Salous
18 years - 100 years
All genders
Phase 2/3
What is this study about?This phase II/III trial examines whether patients who have undergone surgical removal of bladder, but require an additional treatment called immunotherapy to help prevent their bladder cancer from coming back, can be identified by a blood test. Many types of tumors tend to lose cells or …
 Discover a New Path to Hope: Join a Study That’s Working to Improve Care for Depression
S
Steve Strakowski
18 years - 75 years
All genders
Interventional
Take the First Step Toward Feeling Better—Join Our Depression Study Today!Living with depression can feel heavy, even on your best days.  If you’re looking for new options—or simply wondering what else might help—you’re not alone. This research study is exploring a possible new treatment for major depression, and you may be …
T
Tarah Ballinger, MD
18 years - 100 years
All genders
This study investigates the effects of an investigational treatment regimen combined with a checkpoint inhibitor on patients with advanced metastatic breast cancer. Metastatic breast cancer is when cancer cells spread from the breast to other parts of the body. The study compares this combination treatment to the usual treatment chosen …
S
Shelley Johns
18 years - 100 years
Female
This study investigates the fear of cancer occurrence in women who are at a higher risk of developing breast cancer but have not been diagnosed. These women are known as 'previvors.' The purpose of this study is to create a new measure to understand their fear better. Two existing tools …
C
Catherine Sears, MD
40 years or above
All genders
Observational
What is the purpose of this study?This study evaluates the how addition of the Nodify XL2 test result impacts the clinicalgement of newly identified solid lung nodules assessed as low to moderate risk of cancer.THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with most oncology trials, patients are not …
R
Rafat Abonour, MD
18 years or above
All genders
What is the purpose of this study?The purpose of this expanded access program (EAP) is to provide ciltacabtagene autoleucel (cilta-cel) that does not meet the commercial release specifications of CARVYKTI and is notvailable via the local health care system in the country where the treatment is requested.THIS STUDY IS ENROLLING …
631 - 640 of 687